Dogs have been reported as potential carriers of antimicrobial-resistant bacteria, but the role of cats has been poorly studied. The aim of this study was to investigate the presence and the risk factors associated with the fecal carriage of extended-spectrum β-lactamase and AmpC (ESBL/AmpC)-producing Escherichia coli (E. coli) in pet and stray cats. Fecal samples were collected between 2020 and 2022 from healthy and unhealthy cats and screened for ESBL/AmpC-producing E. coli using selective media. The presence of ESBL/AmpC-producing E. coli was confirmed by phenotypic and molecular methods. The evaluation of minimum inhibitory concentrations (MICs) was performed on positive isolates. Host and hospitalization data were analyzed to identify risk factors. A total of 97 cats’ samples were collected, and ESBL/AmpC-producing E. coli were detected in 6/97 (6.2%), supported by the detection of bla_CTX-M (100%), bla_TEM (83.3%), and bla_SHV (16.7%) genes and the overexpression of chromosomal ampC (1%). All E. coli isolates were categorized as multidrug-resistant. Unhealthy status and previous antibiotic therapy were significantly associated with ESBL/AmpC-producing E. coli fecal carriage. Our results suggest that cats may be carriers of ESBL/AmpC-producing E. coli, highlighting the need for antimicrobial stewardship in veterinary medicine and an antimicrobial-resistance surveillance program focusing on companion animals, including stray cats.

Background: In dogs, bacterial urinary tract infections are a frequent cause of antimicrobial prescription, increasing the risk of selecting antibiotic-resistant bacteria. This study analyzed resistance patterns, the presence of extended-spectrum β-lactamases (ESBLs) and biofilm-forming capacity in E. coli and K. pneumoniae previously isolated from urine samples collected from 133 selected dogs admitted to the Veterinary Teaching Hospital of Milan, Italy, in 2021 and 2023. Methods: The E. coli and K. pneumoniae isolates were bacteriologically and genetically analyzed. Results: Overall, 53/133 (39.8%) samples had a positive microbiological culture. Thirty-four E. coli/K. pneumoniae isolates were detected, accounting for 26.5% of the examined samples. The 34 isolates included 28 E. coli and 6 K. pneumoniae. Four (11.8%) were ESBL-producing bacteria, all supported by bla_CTX-M gene belonging to group 1. The K. pneumoniae isolates were significantly associated with ESBL production (p < 0.05). MIC analysis showed 11 (32.4%) multidrug-resistant isolates. Biofilm-forming capacity was observed in 23 (67.6%) isolates, regardless of bacterial species, including 20 weakly and 3 moderately adherent bacteria. All moderate biofilm producers were K. pneumoniae. Multidrug resistance (MDR) was significantly more present in strains with moderate biofilm-forming ability compared to strains with weak ability to form biofilm (p < 0.05). E. coli was confirmed as the most commonly identified urinary isolate in dogs. Conclusions: The high presence of ESBL producers and MDR in K. pneumoniae suggests mandatory in vitro susceptibility testing in the presence of this bacterium in dogs with UTI. The association of moderate biofilm production with MDR highlights the need for monitoring and surveillance of bacterial prevalence and resistance patterns of urinary isolates in dogs.

MDR bacteria are an emerging global threat to public health, and the role of dogs in the rise of antimicrobial resistance is under investigation. This study investigated the fecal shedding of extended-spectrum β-lactamase (ESBL)-, AmpC- and carbapenemase (CP)-producing Escherichia coli and associated risk factors in dogs admitted to the Veterinary Teaching Hospital of Lodi, University of Milan, or other veterinary clinics and kennels in Northen Italy. Feces collected in 2020–2022 were microbiologically and molecularly analyzed. ESBL-/AmpC-/CP-producing E. coli was detected in 14/100 (14%) dogs. Eleven (11%), five (5%) and one (1%) dogs carried ESBL-, AmpC- and CP-producing E. coli phenotypes, respectively, supported by the PCR detection of bla_CTX-M and/or bla_TEM in ESBL-producing E. coli; bla_CMY-2 and the presence of putative low-level AmpC production in AmpC-producing E. coli; and bla_OXA-48 in CP-producing E. coli. Different combinations of resistance genes and genetic features were observed. Multidrug resistance was observed in 13/14 (92.9%) E. coli isolates. Binary logistic regression analysis showed that ESBL-/AmpC-/CP-producing E. coli fecal shedding tended to be associated with antibiotic treatment (p = 0.058; OR = 3.87). The detection of ESBL-/AmpC-producing E. coli, along with the presence of a carbapenemase-resistant E. coli isolate from domestic dogs, although still limited, emphasizes the need for antimicrobial stewardship and specific surveillance programs, particularly for CP-producing bacteria in companion animals.

Background: Antimicrobial resistance mediated by ESBL-producing Klebsiella pneumoniae is an emerging concern in both human and veterinary medicine, with companion animals increasingly considered relevant within the One Health framework. This study aimed to investigate the fecal carriage of ESBL-producing K. pneumoniae complex in cats from Italy and to characterize the strains by the phenotypic and genetic profile of ESBL production, virulent pathotypes, antibiotic resistance profile and biofilm production. Methods: Fecal samples collected from cats admitted to the Veterinary Teaching Hospital of Milan (Italy) in 2020–2026 were bacteriologically and genetically analyzed. Results: All the Klebsiella pneumoniae strains isolated [4/200 (2%, 95% CI: 0.06–3.94%)] were ESBL-producing K. pneumoniae complex isolates harboring bla_CTX-M-15, bla_SHV, and bla_TEM genes. The isolates were detected with higher presence in cats with diarrhea and were found only in cats treated with antibiotics and hospitalized. All four ESBL-producing isolates were classified as the classical K. pneumoniae pathotype based on the negative string test results, the absence of reliable virulence genes used for pathotype identification (peg-344, iucA, rmpA and rmpA2), and the lack of K1 and K2 serotypes, despite the detection of terB and irp2 virulence genes in one and two isolates, respectively. All four ESBL-producing K. pneumoniae complexes were classified as multidrug-resistant, with resistance mainly observed to β-lactams, fluoroquinolones, quinolones and folate antagonists. All four ESBL-producing K. pneumoniae complexes demonstrated biofilm-forming abilities, with two isolates showing weak adhesion, one moderate adhesion, and one strong adhesion. Conclusions: The detection of ESBL genes together with the MDR pattern, biofilm-forming capacity and selected virulence determinants suggests the potential epidemiological relevance of cats in the dissemination of antimicrobial-resistant K. pneumoniae complexes, underscoring the need for strengthened surveillance and prevention strategies in veterinary settings to provide information to pet cat owners and children who may interact with stray cats, in full implementation of the One Health approach.

Background: Feline bocavirus (FBoV) is considered one of the emerging viral agents affecting cats. Methods: this observational study investigated FBoV occurrence by convenience sampling of 224 cats admitted to the Veterinary Teaching Hospital of Lodi, Italy, in 2020–2025 using PCR targeting the NP1 gene. Positive samples were phylogenetically analyzed. Results: FBoV positivity was observed in 17/224 (7.6%) cats. FBoV genotypes 1 (4%), 2 (0.9%) and 3 (2.7%) were identified. Out of the animals with collection of fecal samples, FBoV-positive cats were 17/53 (32.1%), whereas cats with blood (n. 69), respiratory (n. 54), urine (n. 46), or other (n. 2) samples were FBoV-negative. In a subset of cats with more than one fecal sample collected, viral carriage was detected for up to two weeks. Young age, stray/shelter condition and hospitalization were significantly associated with FBoV positivity (p = 0.0008, p = 0.0139 and p = 0.0023, respectively). In cats with analyzed fecal samples, Feline panleukopenia virus (FPV) positivity was associated with FBoV positivity (p < 0.001), whereas presence of diarrhea was not associated with FBoV occurrence. Conclusions: the sampling strategy did not allow us to estimate FBoV prevalence in the cat population. Nevertheless, the circulation of genetically diverse FBoV strains among cats in Italy, the association of FBoV positivity with hospitalization and results suggesting that FBoV may not be a primary pathogen for gastrointestinal disease underscore the importance of comprehensive surveillance studies to enhance the understanding of the evolutionary characteristics, epidemiology and pathogenic role of FBoV.